Back to funds

Lynx1 Capital Management LP

Updated 6 days ago

Managed by Lynx1 Capital Management Lp • Latest filing Q3 2026

Portfolio value
$646.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$494M
Q1 2026$632.7M
Q2 2026$507.6M
Q3 2026$646.1M

Top holdings

31 positions as of Q3 2026

View filing
G

GH RESEARCH PLC

Value
$311.4M
Shares
13.26M
% Port
48.20%
C

CULLINAN THERAPEUTICS INC

Value
$137.6M
Shares
8.96M
% Port
21.30%
S

STOKE THERAPEUTICS INC

Value
$101.3M
Shares
3.90M
% Port
15.68%
B

C4 THERAPEUTICS INC

Value
$25.1M
Shares
7.53M
% Port
3.88%
D

PRECISION BIOSCIENCES INC

Value
$17.3M
Shares
2.76M
% Port
2.67%
M

AGIOS PHARMACEUTICALS INC

Value
$15.7M
Shares
472.6K
% Port
2.43%
K

KORRO BIO INC

Value
$15.3M
Shares
1.54M
% Port
2.37%
N

NEUPHORIA THERAPEUTICS INC

Value
$3.1M
Shares
875.3K
% Port
0.48%
?
9.N/A

PASSAGE BIO INC

Value
$3M
Shares
673.8K
% Port
0.47%
P

PROQR THRAPEUTICS N V

Value
$2.6M
Shares
1.56M
% Port
0.40%
T

TSCAN THERAPEUTICS INC

Value
$2.5M
Shares
8.02M
% Port
0.39%
K

KAZIA THERAPEUTICS LTD

Value
$2.2M
Shares
225.8K
% Port
0.34%
P

PLIANT THERAPEUTICS INC

Value
$1.9M
Shares
1.80M
% Port
0.30%
T

ENTRADA THERAPEUTICS INC

Value
$1.8M
Shares
278.6K
% Port
0.27%
S

SURROZEN INC

Value
$644K
Shares
20.0K
% Port
0.10%
I

IMMATICS N.V

Value
$626K
Shares
71.3K
% Port
0.10%
H

WEREWOLF THERAPEUTICS INC

Value
$607K
Shares
657.8K
% Port
0.09%
Y

YARROW BIOSCIENCE INC

Value
$495K
Shares
22.0K
% Port
0.08%
X

XENCOR INC

Value
$454K
Shares
18.2K
% Port
0.07%
I

IMMUNOCORE HLDGS PLC

Value
$433K
Shares
14.3K
% Port
0.07%

Explore